Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 7 papers. Top paper: “Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy”.
Yashaar Chaichian, Mark C. Genovese, Vimal K. Derebail, Panduranga S. Rao, Winn Chatham +7 more
Larry R. Hearld, Seth A. Eisen, Winn Chatham, Sonali Narain, Narender Annapureddy +20 more
Larry R. Hearld, Seth A. Eisen, Winn Chatham, Sonali Narain, Narender Annapureddy +16 more
Winn Chatham, John D. Mountz, Hui‐Chen Hsu, Kathryn Sullivan
Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +26 more
Huma Fatima, Jennie A Hamilton, Winn Chatham, Hui‐Chen Hsu, John D. Mountz +1 more
Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +45 more